Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Pheton Holdings Ltd (PTHL : NSDQ)
 
 • Company Description   
Pheton Holdings Ltd, through its wholly owned operating subsidiary, Beijing Feitian Zhaoye Technology Co., Ltd., focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its lead product includes Beijing Feitian's Treatment Planning System. Pheton Holdings Ltd is based in BEIJING, China.

Number of Employees: 10

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.93 Daily Weekly Monthly
20 Day Moving Average: 1,794,193 shares
Shares Outstanding: 6.58 (millions)
Market Capitalization: $6.12 (millions)
Beta:
52 Week High: $32.00
52 Week Low: $0.51
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 39.41% 36.89%
12 Week -94.86% -95.33%
Year To Date -78.91% -81.17%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
ROOM 306 NET BUILDING HONGJUNYING SOUTH RD CHAOYANG DISTRICT
-
BEIJING,F4 100012
CHN
ph: 010-84817665
fax: -
None http://www.ftzy.com.cn
 
 • General Corporate Information   
Officers
Jianfei Zhang - Chief Executive Officer and Chairman
Zhixin Li - Chief Financial Officer
Pengfei Zhang - Director
Edward C Ye - Director
Swee Leng Seng - Director

Peer Information
Pheton Holdings Ltd (CHCR)
Pheton Holdings Ltd (ESRX)
Pheton Holdings Ltd (MYDP)
Pheton Holdings Ltd (COR)
Pheton Holdings Ltd (GBCS)
Pheton Holdings Ltd (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: G71399102
SIC: 3845
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding: 6.58
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $6.12 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.99
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
06/30/25 - -
03/31/25 - -
12/31/24 - -
ROA
06/30/25 - -
03/31/25 - -
12/31/24 - -
Current Ratio
06/30/25 - -
03/31/25 - -
12/31/24 - 12.39
Quick Ratio
06/30/25 - -
03/31/25 - -
12/31/24 - 12.17
Operating Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Net Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Pre-Tax Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -142.63
Book Value
06/30/25 - -
03/31/25 - -
12/31/24 - 0.94
Inventory Turnover
06/30/25 - -
03/31/25 - -
12/31/24 - 0.85
Debt-to-Equity
06/30/25 - -
03/31/25 - -
12/31/24 - 0.00
Debt-to-Capital
06/30/25 - -
03/31/25 - -
12/31/24 - 0.00
 

Powered by Zacks Investment Research ©